期刊文献+

基因活化材料在骨科组织损伤修复中的应用 被引量:1

Application of gene-activated-matrix in the repair of orthopaedic tissue injury
下载PDF
导出
摘要 背景:基因活化材料是新型的专为组织工程设计的转基因材料。目前基因活化材料技术在骨科主要用于骨折不愈合、软骨以及肌腱韧带损伤的修复。目的:分析目前基因活化材料在骨科组织损伤修复中的应用,为临床应用提供参考。方法:以"Gene-Activated-Matrix,GAM"英文检索词及"基因活化材料,组织工程,骨与软骨损伤修复,肌腱韧带损伤修复"中文检索词,检索CNKI中国知网数据库和PubMed数据库1999-01/2010-09相关文献128篇。纳入与骨组织工程及基因活化材料有关的基础性、前瞻性及临床性研究,排除标准重复性研究,保留其中的26篇进行分析。结果与结论:目前基因活化材料技术在骨科主要用于骨折、软骨以及肌腱韧带损伤的修复。随着分子生物学和基因工程技术的发展,可利用基因活化材料修复关节软骨损伤,通过转基因的靶细胞持续大量分泌生长因子来修复损伤的关节软骨。目前,基因治疗存在的主要问题是基因转染的安全性、基因表达的可控性、以及寻找合适的基因载体。同时,基因活化材料治疗为韧带和肌腱损伤愈合也提供了新的治疗途径。大量研究表明利用基因活化材料治疗在组织损伤修复方面具有有效性和可行性,但仍面临许多问题需要解决。 BACKGROUND:Gene-activated-matrix(GAM) is a new kind of transgenic matrix designed for tissue engineering. At present GAM is used for repairing of nonunion,cartilaginous injury,ligament and tendon injury in orthopaedics. OBJECTIVE:To analyze the application of GAM in the repair of orthopaedic tissue injury,and to provide reference for further clinical application of GAM in orthopedics METHODS:"Gene-Activated-Matrix,GAM" in English and "gene-Activated-Matrix,GAM,tissue engineering,bone and cartilage injury repair,ligament and tendon injury repair" in Chinese were utilized as search terms to retrieve 128 literatures from CNKI database and PubMed database(1999-01/2010-09) . The researches related to basic,prospective,and clinical study of bone tissue engineering and GAM were included,standard duplicate researches were excluded,26 of them were involved for analysis. RESULTS AND CONCLUSION:GAM is currently mainly used for the repair of fractures,cartilage,and tendon and ligament injury. With the development of molecular biology and genetic engineering technology,GAM can be used to repair articular cartilage injury,the target cells by transgenic continued high secretion of growth factors to repair articular cartilage injury. Currently,the main problems of gene therapy are the safety of gene transfer,the controllability of gene expression,and appropriate gene vector. Meanwhile,GAM treatment also provides a new therapeutic approach for the healing of ligament and tendon injuries. Numerous studies showed that GAM treatment has efficacy and feasibility in tissue injury repair,but still faces many problems to be solved.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第34期6388-6392,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金资助项目(81000792)~~
  • 相关文献

参考文献25

  • 1Bonadio J,Smiley E,Patil P,et al.Localized,direct plasmid gene delivery in vivo:prolonged therapy results in reproducible tissue regeneration.Nat Med.1999;5(7):753-759.
  • 2Berry M,Gonzalez AM,Clarke W,et al.Sustained effects of gene-activated matrices after CNS injury.Mol Cell Neurosci.2001;17(4):706-716.
  • 3Shea LD,Smiley E,Bonadio J,et al.DNA delivery from polymer matrices for tissue engineering.Nat Biotechnol.1999;17(6):551-554.
  • 4Evans CH,Ghivizzani SC,Robbins PD.Orthopedic Gene Therapy in 2008.Mol Ther.2009;17(2):231-244.
  • 5Borrelli J,Prickett WD,Ricci WM.Treatment of nonunions and osseous defects with bone graft and calcium sulfate.Clin Orthop Relat Res.2003;(411):245-254.
  • 6Fang JM,Zhu YY,Smiley E,et al.Stimulation of new bone formation by direct transfer of osteogenic plasmid genes.Proc Natl Acad Sci U S A.1996;93(12):5753-5758.
  • 7Backstrom K C,Bertone A L,Wisner E R,et al.Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene.Am J Vet Res.2004;65(9):1223-1232.
  • 8Geiger F,Bertram H,Berger I,et al.Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects.J Bone Miner Res.2005;20(11):2028-2035.
  • 9Endo M,Kuroda S,Kondo H,et al.Bone regeneration by modified gene-activated matrix:Effectiveness in segmental tibial defects in rats.Tissue Eng.2006;12(3):489-497.
  • 10Ono I,Yamashita T,Jin HY,et al.Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy.Biomaterials.2004;25(19):4709-4718.

二级参考文献74

  • 1Gelse K,vonder Mark K,Schneider H.Curr Gene Ther,2003;3(4):305~317
  • 2Glasson SS,Kim HD,D′Augusta DA,et al.2nd International Symposium of the International Cartilage Repair Society,Boston,1998
  • 3Kotin RM.Hum Gene Ther,1994;5(7):793~801
  • 4Curiel DT,Agarwal S,Wagner E,et al.Proc Natl Acad Sci USA,1991;88(19) 8850~8854
  • 5Evans CH,Robbins PD.Rheum Dis Clin North Am,1999;25(2):333~34
  • 6Evans CH,Ghivizzani SC,Kang R et al.Arthritis Rheum,1999;42(1):1~16
  • 7Fernandes J,Tardif G,Martel Pelletier J,et al.Am J Pathol,1999;154(4):1159~1169
  • 8Boumediene K,Vivien D,Macro M,et al.Cell Prolif,1995;28(4):221~234
  • 9Guerne PA,Sublet A,Lotz M.J Cell Physiol,1994;158(3):476~484
  • 10Loeser RF.Biorheology,2000;37(1 2):109~116

共引文献3

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部